Through this consortium, Lonza will collaborate with other industry leaders to advance the research and development of inhalation technologies
Yashoda Hospitals Hyderabad has earned the distinction of becoming the first to introduce BTVA in India
Evusheld significantly reduced the risk of developing symptomatic COVID-19 in PROVENT Phase III trial, with protection lasting at least six months
The investment will accelerate the overall Sarclisa development program
Guardant360 CDx is a comprehensive genomic profiling test that utilizes blood samples from patients with advanced solid cancers
Use of Wipro Holmes Artificial Intelligence capabilities will lead to faster development of advanced therapeutics, improving patient outcomes
Experts will speak about primary tumours of the nervous system and also the tumours of other body parts which get metastasized to the nervous system
The approval marks the first-and-only immunotherapy-based treatment for use before surgery for non-small cell lung cancer
Intranasal immunization lowers the viral load below the limit of detection in lungs of hamsters
If approved, Opdivo plus chemotherapy would be the first neoadjuvant immunotherapy-based option for patients with resectable non-small cell lung cancer in the U.S.
Subscribe To Our Newsletter & Stay Updated
